West Pharmaceutical Services, Inc. WST
NYSE
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 638.90M | 564.90M | 542.70M | 493.70M | 491.70M |
| Total Depreciation and Amortization | 184.30M | 181.40M | 176.60M | 171.40M | 165.10M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -42.20M | 21.00M | 19.20M | 9.90M | 15.40M |
| Change in Net Operating Assets | -126.50M | -105.10M | -23.20M | 79.80M | 21.60M |
| Cash from Operations | 654.50M | 662.20M | 715.30M | 754.80M | 693.80M |
| Capital Expenditure | -201.10M | -225.30M | -257.30M | -285.90M | -314.70M |
| Sale of Property, Plant, and Equipment | 126.90M | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -8.90M | -- | -- | -- | 100.00K |
| Cash from Investing | -83.10M | -225.30M | -257.30M | -285.90M | -314.60M |
| Total Debt Issued | 50.00M | 50.00M | -- | -- | 0.00 |
| Total Debt Repaid | -51.50M | -51.30M | -1.20M | -1.10M | -900.00K |
| Issuance of Common Stock | 27.40M | 24.90M | 21.30M | 18.20M | 16.70M |
| Repurchase of Common Stock | -689.30M | -457.10M | -300.90M | -136.80M | -191.20M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -62.80M | -62.40M | -61.80M | -61.20M | -60.70M |
| Other Financing Activities | -800.00K | -800.00K | -4.20M | -4.20M | -6.20M |
| Cash from Financing | -727.00M | -496.70M | -346.80M | -185.10M | -242.30M |
| Foreign Exchange rate Adjustments | -8.80M | -14.10M | 6.00M | 22.90M | 700.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -164.40M | -73.90M | 117.20M | 306.70M | 137.60M |